Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, August 30, 2014
 
Register | Sign in
Home Page>Products
  Product News
BioTek’s Gen5 Software Offers CVB Relative Potency Solution
Thursday, August 14, 2014
Company will describe the use of Gen5 software at webinar on September 25, 2014.

Rigaku Concludes Successful 3rd European SmartLab Workshop in Karlsruhe
Thursday, August 14, 2014
Workshop focused on application and operation of the SmartLab Intelligent X-ray diffraction system.

Bioo Scientific First to Address Small RNA-Seq Bias Concerns
Wednesday, August 13, 2014
Company launches NEXTflex™ Small RNA Sequencing Kit v2.

Protagen AG Launches Landmark First Research Test Kit for Systemic Sclerosis
Wednesday, August 13, 2014
The new assay was developed to synergistically combine two proprietary, novel disease markers with two standard diagnostic markers to support medical research in autoimmune diseases.

HORIBA Scientific Releases LabSpec 6.3 Software Update
Tuesday, August 12, 2014
Enhanced capabilities include full 3D volume display for Raman spectroscopy.

UNIConnect Unveils New PrecisionMDx™ LIS-LIMS Process Management Software Suite at AACC 2014
Tuesday, August 12, 2014
Developed for use by industry-leading MDx, CDx and PGx laboratories.

Optibrium Launches SentiraTM: New Software for Compound Data Visualisation
Monday, August 11, 2014
Powerful desktop application simplifies visualisation, interpretation and presentation of compound data.

Cancer Conference Poster Prize Winner Announced
Monday, August 11, 2014
Katarzyna Grzes, winner of the AMSBIO-Trevigen prize for the best poster, is a PhD researcher specialising in Cell Signaling and Immunology.

Luminex is Supporting USAMRIID in Research Efforts to Control African Ebola Outbreak
Friday, August 08, 2014
MAGPIX® system deployed to Africa to support research efforts to control the current outbreak.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 10431
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv